Status:
COMPLETED
INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This trial is conducted in the United States of America (USA). The purpose of this study is to compare the effectiveness and safety of a biphasic insulin aspart standard titration regimen when coupled...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Type 2 Diabetes
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
4877 Patients enrolled
Trial Details
Trial ID
NCT00101751
Start Date
October 1 2004
End Date
June 1 2006
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Clinical Trial Call Center
Princeton, New Jersey, United States, 08540